Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 06:35:50 UTC
Update Date2021-09-26 23:00:48 UTC
HMDB IDHMDB0249744
Secondary Accession NumbersNone
Metabolite Identification
Common NameMethyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate
DescriptionCdri 81-470, also known as compound 81-470, belongs to the class of organic compounds known as 2-benzimidazolylcarbamic acid esters. These are aromatic heteropolycyclic compounds that contain a carbamic acid ester group, which is N-linked to the C2-atom of a benzimidazole moiety. Based on a literature review very few articles have been published on Cdri 81-470. This compound has been identified in human blood as reported by (PMID: 31557052 ). Methyl n-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1h-benzimidazol-2-yl]carbamate is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
5(6)-(4-(2-Pyridylpiperazino)carbamoyl)benzimidazole-2-carbamate methyl esterMeSH
Compound 81-470MeSH
Methyl 5(6)-4-2-pyridyl piperazino carbamoyl benzimidazole-2-carbamateMeSH
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamic acidGenerator
Chemical FormulaC19H21N7O3
Average Molecular Weight395.423
Monoisotopic Molecular Weight395.170587564
IUPAC Namemethyl N-(6-{[4-(pyridin-2-yl)piperazine-1-carbonyl]amino}-1H-1,3-benzodiazol-2-yl)carbamate
Traditional Namemethyl N-{5-[4-(pyridin-2-yl)piperazine-1-carbonylamino]-3H-1,3-benzodiazol-2-yl}carbamate
CAS Registry NumberNot Available
SMILES
COC(=O)NC1=NC2=C(N1)C=C(NC(=O)N1CCN(CC1)C1=CC=CC=N1)C=C2
InChI Identifier
InChI=1S/C19H21N7O3/c1-29-19(28)24-17-22-14-6-5-13(12-15(14)23-17)21-18(27)26-10-8-25(9-11-26)16-4-2-3-7-20-16/h2-7,12H,8-11H2,1H3,(H,21,27)(H2,22,23,24,28)
InChI KeyJEGRFXZWEUCCHQ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 2-benzimidazolylcarbamic acid esters. These are aromatic heteropolycyclic compounds that contain a carbamic acid ester group, which is N-linked to the C2-atom of a benzimidazole moiety.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzimidazoles
Sub Class2-benzimidazolylcarbamic acid esters
Direct Parent2-benzimidazolylcarbamic acid esters
Alternative Parents
Substituents
  • 2-benzimidazolylcarbamic acid ester
  • N-arylpiperazine
  • Pyridinylpiperazine
  • Piperazine-1-carboxamide
  • Dialkylarylamine
  • Aminopyridine
  • 1,4-diazinane
  • Piperazine
  • Imidolactam
  • Benzenoid
  • Pyridine
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Carbamic acid ester
  • Carbonic acid derivative
  • Urea
  • Azacycle
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Organic oxide
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.51ALOGPS
logP2.27ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)9.47ChemAxon
pKa (Strongest Basic)6.42ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area115.48 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity108.97 m³·mol⁻¹ChemAxon
Polarizability41.17 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+189.11730932474
DeepCCS[M-H]-186.75930932474
DeepCCS[M-2H]-220.54130932474
DeepCCS[M+Na]+195.76930932474
AllCCS[M+H]+192.932859911
AllCCS[M+H-H2O]+190.432859911
AllCCS[M+NH4]+195.232859911
AllCCS[M+Na]+195.932859911
AllCCS[M-H]-192.032859911
AllCCS[M+Na-2H]-192.032859911
AllCCS[M+HCOO]-192.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamateCOC(=O)NC1=NC2=C(N1)C=C(NC(=O)N1CCN(CC1)C1=CC=CC=N1)C=C24739.0Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamateCOC(=O)NC1=NC2=C(N1)C=C(NC(=O)N1CCN(CC1)C1=CC=CC=N1)C=C23416.1Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamateCOC(=O)NC1=NC2=C(N1)C=C(NC(=O)N1CCN(CC1)C1=CC=CC=N1)C=C24391.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C3831.5Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C3401.9Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C5612.0Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C3934.0Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C3451.0Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C5715.1Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]13810.8Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]13362.1Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]15541.1Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]1)[Si](C)(C)C3567.0Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]1)[Si](C)(C)C3266.6Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2[NH]1)[Si](C)(C)C5023.1Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C)[Si](C)(C)C3781.5Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C)[Si](C)(C)C3410.5Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C)[Si](C)(C)C5251.2Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C3703.9Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C3352.5Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C5134.7Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C)[Si](C)(C)C3625.5Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C)[Si](C)(C)C3336.2Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C)C=C2N1[Si](C)(C)C)[Si](C)(C)C4630.9Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C(C)(C)C4005.8Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C(C)(C)C3638.1Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2[NH]1)[Si](C)(C)C(C)(C)C5545.1Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C4119.2Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C3703.5Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #2COC(=O)NC1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C5646.7Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]14007.3Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]13561.3Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,1TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]15503.0Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]1)[Si](C)(C)C(C)(C)C3938.4Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]1)[Si](C)(C)C(C)(C)C3690.8Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2[NH]1)[Si](C)(C)C(C)(C)C4962.4Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4102.1Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3874.6Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #2COC(=O)N(C1=NC2=CC=C(NC(=O)N3CCN(C4=CC=CC=N4)CC3)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C5141.4Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C4056.0Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C3774.1Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,2TBDMS,isomer #3COC(=O)NC1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C5063.9Standard polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4102.3Semi standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3962.3Standard non polar33892256
Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate,3TBDMS,isomer #1COC(=O)N(C1=NC2=CC=C(N(C(=O)N3CCN(C4=CC=CC=N4)CC3)[Si](C)(C)C(C)(C)C)C=C2N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4686.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate GC-MS (Non-derivatized) - 70eV, Positivesplash10-06r5-0793000000-a2e0d58bbd39b1659ef82021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 10V, Positive-QTOFsplash10-0002-0009000000-8508dfcc5e0b38338a172021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 20V, Positive-QTOFsplash10-03di-0629000000-bf548542b83f37c34dcc2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 40V, Positive-QTOFsplash10-00di-1911000000-63b7c59f669498b9c1962021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 10V, Negative-QTOFsplash10-03di-0609000000-cb82630c2c26f492d09d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 20V, Negative-QTOFsplash10-03di-0319000000-1485cb1f7373c7396b0b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Methyl N-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1H-benzimidazol-2-yl]carbamate 40V, Negative-QTOFsplash10-0230-1925000000-514376e169444954b5c22021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID129162
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound146439
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]